New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis. [electronic resource]
Producer: 20160328Description: 63-76 p. digitalISSN:- 1175-8716
- Adalimumab -- therapeutic use
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Appendectomy
- Azathioprine -- therapeutic use
- Colitis, Ulcerative -- therapy
- Cyclosporine -- therapeutic use
- Drug Resistance
- Drug Therapy, Combination
- Fecal Microbiota Transplantation
- Gastrointestinal Agents -- therapeutic use
- Humans
- Immunosuppressive Agents -- therapeutic use
- Infliximab -- therapeutic use
- Leukapheresis
- Mercaptopurine -- therapeutic use
- Mesalamine -- therapeutic use
- Methotrexate -- therapeutic use
- New Zealand
- Pediatrics
- Piperidines -- therapeutic use
- Proctocolectomy, Restorative
- Protein Kinase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Pyrroles -- therapeutic use
- Recurrence
- Severity of Illness Index
- Tacrolimus -- therapeutic use
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Practice Guideline
There are no comments on this title.
Log in to your account to post a comment.